Koers Lexington BioSciences Inc Other OTC
Aandelen
CA5290201097
Medische apparatuur, benodigdheden & distributie
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 35,62 32,69 |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 | Nettowinst (verlies) 2023 | - 0 | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 * | - 0 | Nettoliquiditeiten 2023 * | - 0 | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-
| K/w-verhouding 2023 |
-
| Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 13,79% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Donald McInnes
CEO | Chief Executive Officer | 60 | 16-04-20 |
Bryan Disher
DFI | Director of Finance/CFO | 66 | 21-12-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Bryan Disher
DFI | Director of Finance/CFO | 66 | 21-12-16 |
Tamara Manuel
BRD | Director/Board Member | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-6,68% | 179 mld. | |
-5,20% | 98,84 mld. | |
-5,38% | 65,34 mld. | |
+17,99% | 45,41 mld. | |
-6,47% | 44,94 mld. | |
+9,74% | 43,76 mld. | |
+14,01% | 29,01 mld. | |
+21,29% | 25,65 mld. | |
-6,53% | 23,32 mld. |